Pierre Fabre Overview

  • Founded
  • 1951
Founded
  • Status
  • Private
  • Employees
  • 10,000
Employees
  • Latest Deal Type
  • Debt
  • Latest Deal Amount
  • $138M
Latest Deal Amount

Pierre Fabre General Information

Description

Owner and operator of pharmaceutical and cosmetics company intended to assist in research and development through medical innovation. The company's services are offered through an innovation laboratory that promotes research and development in pharmaceuticals, cosmetics and biotechnological domains so as to develop new drugs and health-friendly products without using chemicals and toxic ingredients, enabling medical researchers to recommend and develop all natural healthcare products abiding by the legal compliance and governmental regulations.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Private Debt Financed
Primary Industry
Pharmaceuticals
Primary Office
  • 12, Avenue Hoche
  • 75008 Paris
  • France
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Pierre Fabre Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Debt - General 18-Nov-2011 $138M 00000 Completed Profitable
To view Pierre Fabre’s complete valuation and funding history, request access »

Pierre Fabre Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Owner and operator of pharmaceutical and cosmetics company intended to assist in research and development through medica
Pharmaceuticals
Paris, France
10,000 As of 2021
00000
000000000 00000

000000 0

lore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui off
000000000000000
Mumbai, India
0000 As of 0000

00000000

ion ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit
000000000000000
Ingelheim am Rhein, Germany
00000 As of 0000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Pierre Fabre Competitors (8)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Abbott India Corporation Mumbai, India 0000
0000000000 0000000 Corporation Ingelheim am Rhein, Germany 00000
00000000 000000000 Formerly VC-backed Allschwil, Switzerland 0000 00000 000000&0 00000
00000 Corporation Mumbai, India 00000 00000000
0000000 000000000 Corporate Backed or Acquired Balcatta, Australia 000000&0
You’re viewing 5 of 8 competitors. Get the full list »

Pierre Fabre Patents

Pierre Fabre Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3889183-A1 A protein complex comprising an immunocytokine Pending 01-Apr-2020 000000000
EP-3735904-A1 Detecting nicotine in sweat Withdrawn 09-May-2019 00000000000 0
FR-3095759-A1 Agrimony extract as an anti-pollution agent Pending 07-May-2019 00000000
FR-3090385-B1 Emollient composition in the form of an emulsion Active 21-Dec-2018 0000000000
FR-3090385-A1 Emollient composition in emulsion form Granted 21-Dec-2018 A61K9/0014 0

Pierre Fabre Executive Team (8)

Name Title Board Seat Contact Info
Frederic Duchesne President & Chief Executive Officer of pharmaceuticals division
Eric Ducournau Chief Executive Officer
Laurent Fredon Head of External Innovation in Consumer Healthcare
Eric Gouy Senior Vice President of Finance
Clément Rattier Analyst, Corporate Licensing and Acquisitions
You’re viewing 5 of 8 executive team members. Get the full list »

Pierre Fabre Board Members (1)

Name Representing Role Since
Roch Doliveux Self Chairman of Supervisory Board 000 0000
To view Pierre Fabre’s complete board members history, request access »

Pierre Fabre Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Pierre Fabre Investments & Acquisitions (8)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00 00ô00 0000 22-Nov-2021 0000000000 Personal Products 0000 0000
000000 000000 27-Sep-2021 0000 00000 00.000 Drug Discovery
0000000000 09-Apr-2021 00000 0000 000.00 Drug Discovery
000000 00000 25-Apr-2018 00000 0000 000.00 Pharmaceuticals
Igenica Biotherapeutics (immune oncology asset) 24-May-2017 Corporate Asset Purchase Buildings and Property
You’re viewing 5 of 8 investments and acquisitions. Get the full list »

Pierre Fabre Subsidiaries (1)

Company Name Industry Location Founded
00 00ô00 000000ç00 Personal Products Saillans, France 0000
To view Pierre Fabre’s complete subsidiaries history, request access »

Pierre Fabre Exits (2)

Company Name Exit Date Exit Type Exit Size Status Buyers
0000000 28-Apr-2015 00000 00000 00 00000 Completed
  • 000000 00000
Rovafarm Argentina 01-Jan-1989 Merger/Acquisition Completed
To view Pierre Fabre’s complete exits history, request access »